درباره این اپیزود
Multiple System Atrophy progresses faster than Parkinson's, attacks multiple systems at once, and takes an average of seven doctors before patients receive the correct diagnosis. There is currently no approved treatment.
On this episode of Vantage Point Podcast, we sit down with David Stamler (CEO) and Daniel Claassen (CMO) of Alterity Therapeutics to discuss their drug candidate ATH434, phase two results showing nearly 50% reduction in disease progression rate, and the path to a phase three trial.
We also cover Alterity's orphan drug and fast track FDA designations, upcoming phase three study design discussions, and the drug's potential beyond MSA - including Parkinson's and Friedreich's Ataxia.
انگلیسی
استرالیا
رونوشت 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
جستجوی اپیزودهای گذشته
اپیزودهای قبلی Vantage Point: Driving Success in the Australian Market را جستجو کن.
قسمت های دیگر در این پادکست
In this episode we’re joined by Executive Chairman of Green360 (GT3:ASX), Aaron Banks.
Cement is the second most consumed product on earth after water, and the industry generates roughly 8% of global emissions — the equivalent of the entire global car fleet. Yet the chemistry behind it hasn’t mean…
Elsight (ASX: ELS) is the connectivity layer powering the world’s drones and unmanned systems, and the company’s transformation over the past 12 months has been one of the most compelling operational stories on the ASX.
We sat down with Yoav Amitai, CEO of Elsight, who joined the company as an ope…
On the latest episode of Vantage Point Podcast, Nick Leitl joinsus to discuss the journey from fund manager to co-founder of LSN Capital Partners and what it takes to build and grow an investment business from the ground up.
Drawing on more than two decades in markets, including 16 years managing m…
Most businesses are using AI the same way; typing prompts into ChatGPT or Claude and hoping for the best. As business usage proliferates during the rush to harness AI, the question of who governs these models, and how, is becoming one of the most important problems the world must face.
On the lates…
سلب مسئولیت: پادکست و آثار هنری تعبیه شده در این صفحه متعلق به NWR Communications است که متعلق به صاحب آن است و به Listen Notes، Inc وابسته یا تایید نشده است.
ویرایش
از کمک شما برای بروز نگهداشتن پایگاهدادههای پادکست سپاسگزاریم
